Development of Novel Tavapadon Analogs as Dual-targeted Partial Agonists Based on the Dopamine D<sub>1</sub>/D<sub>5</sub> Receptors
Tavapadon is a potent, selective G protein-biased partial agonist for the dopamine D1/D5 receptors, with positive experimental results in phase 3 trials for the treatment of Parkinson's disease (PD). This study aims to study the structure–activity relationship (SAR) of tavapadon to discover nov...
Saved in:
Main Authors: | Fan Shi, Jian Jia, Zhijing Hu, Yini Yang, Peng Xie, Zehong Wan, Guan Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Georg Thieme Verlag KG
|
Series: | Pharmaceutical Fronts |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/a-2638-1667 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Locomotor activity depends on β-arrestin recruitment by the dopamine D1 receptor in the striatal D1-D3 receptor heteromer
by: Alexandra H. Evans, et al.
Published: (2025-08-01) -
Dopamine Partial Agonists in Pregnancy and Lactation: A Systematic Review
by: Alexia Koukopoulos, et al.
Published: (2025-07-01) -
Associations between dopamine D2 receptor gene polymorphisms and schizophrenia risk: a PRISMA compliant meta-analysis
by: He HR, et al.
Published: (2016-12-01) -
Dopamine D2 receptor gene Taq 1A polymorphism: genetic architecture in Indian population and comparison to global populations
by: Amrita Chaudhary, et al.
Published: (2025-07-01) -
Combined inhibition of dopamine D1/D2 receptors induces cognitive and emotional dysfunction through oxidative stress and dopaminergic neuron damage
by: Xue Li, et al.
Published: (2025-08-01)